| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/28/1995 | EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 06/28/1995 | EP0659193A1 Platelet aggregation inhibitors |
| 06/28/1995 | EP0659191A1 Cloning and expression of pur protein |
| 06/28/1995 | EP0659086A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| 06/28/1995 | EP0659085A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 06/28/1995 | EP0659045A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins |
| 06/28/1995 | EP0642350A4 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties. |
| 06/28/1995 | EP0625157A4 PLATELET GPIIIa P1?A1 AND P1?A2 EPITOPES, THEIR PREPARATION AND USE. |
| 06/28/1995 | EP0539405B1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 06/28/1995 | EP0513073B1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES |
| 06/28/1995 | EP0494268B1 Method for inhibiting growth of stem cells |
| 06/28/1995 | EP0460171B1 Cd3 specific recombinant antibody |
| 06/28/1995 | EP0457758B1 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 06/28/1995 | EP0439540B1 Antibody conjugates with two or more covalently linked fc regions |
| 06/28/1995 | EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae |
| 06/28/1995 | EP0432218B1 Method for detecting cellular pathology |
| 06/28/1995 | CN1104252A Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
| 06/28/1995 | CN1104251A Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
| 06/28/1995 | CN1104217A Peptides having T cell helper activity |
| 06/28/1995 | CN1029131C Process for transforming human insulin precarsor to human insulin |
| 06/27/1995 | US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions |
| 06/27/1995 | US5428147 Octopine T-DNA promoters |
| 06/27/1995 | US5428146 Wound-stimulated DNA-sequence from solanum tuberosum and its use |
| 06/27/1995 | US5428145 Isolated RNA |
| 06/27/1995 | US5428144 Isolation of coat protein gene and incorporation into an expression cassette for the plant cell system; transformed vetor introduced into maize callus to provide cross-protection against viral infection |
| 06/27/1995 | US5428143 A chimeric gene which encodes a hybrid protein capable of binding to an HIV infected cell |
| 06/27/1995 | US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system |
| 06/27/1995 | US5428134 Antibody reagents that specifically bind to the carboxyl-terminal decaptide of specific GTP-binding proteins |
| 06/27/1995 | US5428131 Archaebacterial chaperonin-mediated protein stabilization |
| 06/27/1995 | US5428130 Cell surface adhesion molecules and ligands |
| 06/27/1995 | US5428129 Peptides and processes for producing cyclic peptides |
| 06/27/1995 | US5428128 Forming amino acid chain of polypeptide, conjugating non-antigenic polymer to blocking groups, introducing said polymer at each point of synthesis, continuing synthesis of amino acid chain |
| 06/27/1995 | US5428025 Method of treating inflammation by blocking ELAM-1 receptor sites |
| 06/27/1995 | US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use |
| 06/27/1995 | US5428020 Cysteine (NPYS)-containing peptides and use thereof for inhibiting platelet aggregation |
| 06/27/1995 | US5428018 Phenylalanine analogs of bombesin |
| 06/27/1995 | US5428016 Having atleast one amidated C-terminal or an acetylated N-terminal, and containing 5,6 or 11 amino acid residues |
| 06/27/1995 | US5428015 Vasoactive intestinal polypeptide analogues and use thereof |
| 06/27/1995 | US5428014 Transglutaminase cross-linkable polypeptides and methods relating thereto |
| 06/27/1995 | US5428012 Oncostatin M and novel compositions having anti-neoplastic activity |
| 06/27/1995 | US5428010 Biologically active B-chain homodimers |
| 06/27/1995 | US5428008 Comprising glycoproteins and phospholipids |
| 06/27/1995 | US5428007 Increasing oxygenation in hypoxic cells of normal and tumor tissue |
| 06/27/1995 | US5427954 Detection of aggrecan by-products |
| 06/27/1995 | US5427949 Biosynthetic cerebrospinal fluid control |
| 06/27/1995 | US5427942 Human D5 dopamine recepltor gene and uses |
| 06/27/1995 | US5427940 Engineered cells producing insulin in response to glucose |
| 06/27/1995 | US5427939 Expression vectors encoding alloantigens of glycoprotein Ibα |
| 06/27/1995 | US5427937 Hookworm anticoagulant |
| 06/27/1995 | US5427934 Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
| 06/27/1995 | US5427927 Modifying junction region between two components of fusion protein to form immunoglobulin A protease recognition site, cleaving, isolating component |
| 06/27/1995 | US5427926 Anticoagulant; sulfated glycoprotein |
| 06/27/1995 | US5427925 Recombniant method for making leukemia inhibitor factor |
| 06/27/1995 | US5427924 Gene regulation cassettes, expression vectors containing the same and microorganisms transformed with the same |
| 06/27/1995 | US5427922 DNA encoding a new angiotensin II type 1 receptor subtype and its expression |
| 06/27/1995 | US5427918 Incubating plasminogen activator with fibrinogen degradation product containing methionine oxidized to sulfoxide; chromatography |
| 06/27/1995 | US5427908 Transforming cell with filamentous bacteriophage expression vector, culturing for expression and assembly of particle with antibody Fab fragment on coat, selecting encoding particle by binding to specific ligand, removing nonbinding particles |
| 06/27/1995 | US5427907 Using a synthetic peptide as an antigen in immonoassay for detection of antibodies |
| 06/27/1995 | US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
| 06/27/1995 | US5427788 Pertussis toxin and use in vaccines |
| 06/27/1995 | US5427785 Rhizosheric bacteria |
| 06/27/1995 | US5427781 Administering in conjunction with chemotherapeutic agents |
| 06/27/1995 | US5427780 Composition comprising Mullerian inhibiting substance-like polypeptides |
| 06/27/1995 | CA1336120C Baculovirus proteins and viral pesticides containing same |
| 06/27/1995 | CA1336119C Vinca derivative conjugates containing a c-3 detergent chain |
| 06/27/1995 | CA1336076C Metal radionuclide labeled proteins for diagnosis and therapy |
| 06/27/1995 | CA1336075C Vector comprising a replication competent hiv-1 provirus and a heterologous gene |
| 06/25/1995 | CA2138823A1 Carrot 16 kd protein, gene coding for said protein and plasmid containing said gene |
| 06/23/1995 | CA2138099A1 Enzymatic conversion of proteins using immobilized dictyostelium dipeptidylaminopeptidase |
| 06/22/1995 | WO1995016919A2 Methods and compositions for the detection of colon cancers |
| 06/22/1995 | WO1995016918A1 Combinatorial libraries and methods for their use |
| 06/22/1995 | WO1995016917A1 Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto |
| 06/22/1995 | WO1995016915A1 METHODS AND MATERIALS FOR THE DETECTION OF $i(STAPHYLOCOCCUS AUREUS) |
| 06/22/1995 | WO1995016793A1 Compositions and methods relating to dna mismatch repair genes |
| 06/22/1995 | WO1995016784A1 Human interferon expression vectors for treating aids |
| 06/22/1995 | WO1995016781A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 06/22/1995 | WO1995016780A1 Antiviral composition of viral protein trans-dominant variants |
| 06/22/1995 | WO1995016779A1 Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition |
| 06/22/1995 | WO1995016778A1 Control of aphids with bacillus thuringiensis toxin proteins |
| 06/22/1995 | WO1995016777A1 Purification of insulin-like growth factor |
| 06/22/1995 | WO1995016776A1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi |
| 06/22/1995 | WO1995016774A1 Method for inducing dna synthesis in neurons |
| 06/22/1995 | WO1995016772A1 Adenovirus gene expression system |
| 06/22/1995 | WO1995016771A1 Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby |
| 06/22/1995 | WO1995016711A1 Antibodies against pneumolysine and their applications |
| 06/22/1995 | WO1995016710A1 Specific hyperimmune anti-hiv globulin for passive immunization |
| 06/22/1995 | WO1995016709A2 Anti-mullerian hormone receptor polypeptides and antibodies thereto |
| 06/22/1995 | WO1995016708A1 Proinsulin-like compounds |
| 06/22/1995 | WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY |
| 06/22/1995 | WO1995016706A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 06/22/1995 | WO1995016705A1 Vpr receptor protein |
| 06/22/1995 | WO1995016704A1 Hepatitis b virus peptides |
| 06/22/1995 | WO1995016703A1 Igf-1 analogs |
| 06/22/1995 | WO1995016702A1 Peptide inhibitors of cxc intercrine molecules |
| 06/22/1995 | WO1995016701A1 Method for purifying polypeptides |
| 06/22/1995 | WO1995016697A1 Recombinant bovine conglutinin and fragments thereof |
| 06/22/1995 | WO1995016694A1 Origin of replication complex genes, proteins and methods |
| 06/22/1995 | WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
| 06/22/1995 | WO1995016460A1 Composition containing soluble thrombomodulins |
| 06/22/1995 | WO1995016353A1 Systemic gene treatment of connective tissue diseases |